Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, presenting promising enhancements across many clinical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, additional reliable option for therapeutic u